Multicenter, Randomized, Non-inferiority Study to Compare the Performance and Safety of Debrisoft® Duo With Debrisoft® Pad in the Debridement of Wounds

Exclusion Criteria

• •Known allergy and/or hypersensitivity to Debrisoft® Duo or any of the product components
• •Pregnancy or breast feeding
• •Patient is illiterate
• •Participation in a interventional clinical trial within the last 14 days and during participation in this study
• •Any other medical condition, which, by opinion of the investigator, may have impact of the success of the study treatment and/ or interpretation of the study results
• •severe pain or hyperesthesia in the wound area
• •history of drug or alcohol abuse
• •chronic analgesic use (especially opioids) that could influence baseline pain perception
• •cognitive impairment, which may affect the ability to accurately self-report pain
• •Use of anaesthesia before the debridment procedure
• •presence of hard necrotic tissue or other tissue which should not be debrided in general. Other types of hard necrotic tissue requiring debridement, as determined by the investigator, are permitted and may be also pre-moistened before the procedure if deemed necessary